GSTT1 and GSTM1 polymorphism in cigarette smokers with head and neck squamous cell carcinoma

Revista Brasileira de Otorrinolaringologia

Leal, Renata Cristina de Angelo Calsaverini¹  Faculdade de Medicina de São José do Rio Preto¹  Maníglia, José Victor¹  Rossit, Andréa Regina Baptista¹  Ruiz, Mariângela Torreglosa¹  Biselli, Joice Matos¹  Goloni-Bertollo, Eny Maria¹  Pavarino-Bertelli, Érika Cristina¹ 

关键词: Head and neck neoplasms;    Polymorphism;    Tobacco;    Alcohol;    Glutathione transferase;   

DOI  :  10.1590/S0034-72992006000500012

学科分类：医学（综合）

来源: Associacao Brasileira de Otorrinolaringologia e Cirurgia Cervicofacial

【 摘 要 】

Head and neck neoplasms are responsible for many deaths worldwide, being the sixth cause of death by câncer.1 The most frequent histological type is the squamous cell carcinoma, which is found in over 90% of cases,2-4 and is usually associated with the use of alcohol and tobacco.5-9 It is known that cigarette smoke is a complex mixture of over 4,000 substances, of which at least 40 are carcinogenic, initiating or promoting tumors in animals.10 Levels of electrophilic products launched into the bloodstream depend on the action of enzymes involved in biometabolism, which includes activation (Phase I) and detoxification (Phase II) of chemical compounds.10,11 Polymorphisms in genes that codify these enzymes may alter their expression or function, altering carcinogenic compounds biometabolism12.Various polymorphic genes that code enzymes involved in carcinogen biotransformation have been associated with cancer development.13-22 Two genes in particular - GSTT1 and GSTM1 - that code phase II enzymes belonging to the glutathione S-transferases (GSTs) family seem relevant for susceptibility to head and neck squamous cell carcinoma; they detoxify carcinogenic tobacco smoke reactive metabolites.11-12,13,15,18,20,23The GSTM1 gene is polymorphic in humans, including a null-activity allele (GSTM1-) due to a major genic deletion, and two functional alleles (GSTM1A and GSTM1B). The GSTT1 gene is also polymorphic in humans, and may have a deletion null genotype.24,25 Individuals that have one of these null genotypes in homozygosis may be grouped into the negative conjugating phenotype, where there is complete loss of enzyme activity,26,27 while those that have at least one functional allele are grouped in the positive conjugating phenotype.28Thus, individual gene variability in the metabolic activation and detoxification process appears to be crucial to head and neck cancer susceptibility.This study aimed to identify GSTT1 and GSTM1 gene null genotypes in smokers with head and neck squamous cell carcinoma and to compare these frequencies with those seen in smokers without a history of cancer, to identify possible susceptibility biomarkers for head and neck cancer. MATERIAL AND METHODSIndividuals diagnosed with squamous cell head and neck carcinomas confirmed by histopathology came from the Department of Otorhinolaryngology and Head and Neck Surgery of the Navy Hospital / Medical School of São José do Rio Preto and the Arnaldo Vieira de Carvalho Institute, SP. The control group included individuals with no history of neoplastic disease, paired by gender, age, ethnic group and use of alcoholic beverages. All subjects (patients and controls) were smokers. Individuals were included in the study after signing a free and informed consent form, and all information was obtained using a confidential standardized data-collection questionnaire (gender, ethnic group, smoking and use of alcohol). Information on smoking and alcohol-drinking was limited to a definition of user or non-user. The study was approved by the Research Ethics Committee of the Sao Jose do Rio Preto Medical School (CEP-FAMERP - 5639/2002) and the National Research Ethics Council (CONEP - legal process nº 842/2003).Genomic DNA was extracted from peripheral blood according to the Abdel-Rahman et al technique.29 A sample of peripheral blood was collected in a test tube containing anticoagulant (EDTA) and lymphocytes were isolated using the Ficoll-Paque Plus. Genomic DNA was obtained by adding SDS (Sodium Dodecyl Sulphate), proteinase K and RNAse A to the isolated lymphocytes. Following NaCl purification, DNA was precipitated with ethanol and stored at -20ºC in a Tris-EDTA buffer solution for later analysis.The analysis of GSTT1 and GSTM1 genes was simultaneously done by the chain reaction (PCR) according to Abdel-Rahman et al.30 Amplification of the DNA sequence of interest was obtained in 35 cycles that included DNA denaturing steps at 94ºC for 2 minutes, annealing of reaction-initiator sequences (primers) at 59ºC for 1 minute, and DNA chain extension by nucleotide addition at 72ºC for 1 minute. A CYP1A1 gene exon 7 sequence was co-amplified to serve as an internal amplification control. PCR products were analyzed in agarose gel at 1.5%, stained with ethydium bromide, and the null genotype (both alleles with a deletion) for the GSTT1 and GSTM1 genes was identified by the absence of amplification fragments of 480 base pairs (bp) and 219 bp respectively. Presence of the 312 bp fragment corresponded to the amplified CYP1A1 gene sequence, which was evidence of a successful amplification reaction.Demographics were presented as mean ± standard deviation (SD) or proportions. For the statistical analysis of the genotype frequencies obtained we used the exact Fisher test, with a significance level below 5%. RESULTSDemography data: 120 individuals were recruited, of which 60 had head and neck squamous cell carcinoma (average age 54.6 ± 8 years) and 60 had no history of neoplastic disease (average age 54 ± 9 years). Men predominated (90% men vs. 10% women) and there were more alcohol drinkers (70% alcoholics vs. 30% non-alcoholics). Primary sites: all head and neck squamous cell carcinoma cases were diagnosed and confirmed by pathology exams. The distribution of the primary tumor site is shown on Table 1. Mouth cancers were the most frequent type.   Frequency of polymorphisms: The GSTT1 null genotype [-] was found in 33.3% (20 of 60) of patients and in 23.3% (14 of 60) of controls (P = 0.311). The GSTM1 null genotype [-] was found in 21 (35%) of patients and 29 (48.3 %) of controls (p = 0.582). The combined GSTT1 and GSTM1 gene null genotype was seen in 10% (6 of 60) of patients and in 8.3% (5 of 60) of controls (p = 1.0). The most frequent genotypic combination, considering the presence of an unfavorable genotype (null GST), was GSTT1 [+] / GSTM1 [-] in 31.6% (19 of 60) of patients and 40% (24 of 60) of controls (p = 0.353) (Table 2).  Genotypes were grouped by tumor site (Table 3) and there was no correlation with GSTT1 and GSTM1 null genotypes.  Statistical analysis did not reveal any relation between alcohol use and GSTT1 and GSTM1 null genotypes [-] when we compared alcohol-drinking patients and controls (GSTT1, p = 0.34; GSTM1, p = 0.28; GSTM1[-] / GSTT1[-], p = 1.0). DISCUSSIONEpidemiological data has suggested that alcohol use and smoking are the main risk factors for malignant transformation in head and neck cancers.31,32 It is difficult to assess the individual effect of these agents on the genesis of head and neck cancer. Smokers tend to consume alcohol and alcohol drinkers tend to smoke. Furthermore, in past decades the evidence has show that both factors operate synergistically, and as such may be the main cause of tumors.32Studies have shown an association between alcohol drinking and the development of head and neck tumors when taking into account exposure time and the amount of alcohol consumed.12,34 In our study, 70% of patients with cancer drink alcoholic beverages, which strengthens the association between alcohol use and the development of head and neck cancer. This is especially true in a sample that includes smokers. Unfortunately we were unable to obtain information about the amount of alcohol that was consumed or the exposure time.The higher number of men in this study corroborates findings by Drummond et al,22 although our

【 授权许可】

Unknown